Laboratory Corporation of America Holdings
NYSE:LH

Watchlist Manager
Laboratory Corporation of America Holdings Logo
Laboratory Corporation of America Holdings
NYSE:LH
Watchlist
Price: 239.67 USD -0.21% Market Closed
Market Cap: 20B USD
Have any thoughts about
Laboratory Corporation of America Holdings?
Write Note

Laboratory Corporation of America Holdings
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Laboratory Corporation of America Holdings
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Laboratory Corporation of America Holdings
NYSE:LH
Other Long-Term Assets
$612.6m
CAGR 3-Years
13%
CAGR 5-Years
10%
CAGR 10-Years
16%
DaVita Inc
NYSE:DVA
Other Long-Term Assets
$219m
CAGR 3-Years
29%
CAGR 5-Years
14%
CAGR 10-Years
13%
Chemed Corp
NYSE:CHE
Other Long-Term Assets
$55.7m
CAGR 3-Years
88%
CAGR 5-Years
44%
CAGR 10-Years
21%
Quest Diagnostics Inc
NYSE:DGX
Other Long-Term Assets
$272m
CAGR 3-Years
21%
CAGR 5-Years
12%
CAGR 10-Years
2%
CVS Health Corp
NYSE:CVS
Other Long-Term Assets
$8.1B
CAGR 3-Years
-6%
CAGR 5-Years
-2%
CAGR 10-Years
18%
Cigna Corp
NYSE:CI
Other Long-Term Assets
$15.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
95%
No Stocks Found

Laboratory Corporation of America Holdings
Glance View

Market Cap
20.1B USD
Industry
Health Care

Laboratory Corporation of America Holdings, commonly referred to as LabCorp, has established itself as a leader in the biomedical testing and diagnostics industry. Founded in 1971, the company operates with a mission to improve health and improve lives by providing critical laboratory services to healthcare providers, pharmaceutical companies, and patients. LabCorp offers a comprehensive range of tests, encompassing everything from routine blood work to complex genomic testing. This diverse portfolio positions LabCorp to benefit from the growing demand for diagnostic services, particularly as healthcare continues to evolve toward precision medicine and personalized care. For investors, LabCorp's strategic initiatives and strong financial performance paint a compelling picture. The company has successfully expanded through a series of acquisitions, enhancing its capabilities and market reach. With a focus on innovation, LabCorp has invested heavily in advanced technologies and digital solutions to streamline operations and enhance customer experience. As the healthcare landscape shifts toward value-based care, LabCorp is well-positioned to capture market share and drive revenue growth. With a history of consistent earnings and a commitment to shareholder value, LabCorp represents a potentially attractive investment for those looking to engage in the evolving healthcare sector.

LH Intrinsic Value
259.89 USD
Undervaluation 8%
Intrinsic Value
Price

See Also

What is Laboratory Corporation of America Holdings's Other Long-Term Assets?
Other Long-Term Assets
612.6m USD

Based on the financial report for Sep 30, 2024, Laboratory Corporation of America Holdings's Other Long-Term Assets amounts to 612.6m USD.

What is Laboratory Corporation of America Holdings's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
16%

Over the last year, the Other Long-Term Assets growth was 32%. The average annual Other Long-Term Assets growth rates for Laboratory Corporation of America Holdings have been 13% over the past three years , 10% over the past five years , and 16% over the past ten years .

Back to Top